Stereotaxis, Inc.
STXS- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001289340
No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Stereotaxis, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- −3 vs. Q4 2021
- Shares held
- 40.2M
- −1.90M (−4.5%) vs. Q4 2021
- Total value
- $150.1M
- −$111.0M (−42.5%) vs. Q4 2021
- New holders
- 13
- 24 more added
- Sold out
- 16
- 36 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 108 | $74.1M |
| Q1 2026 | 115 | $79.0M |
| Q4 2025 | 105 | $98.3M |
| Q3 2025 | 104 | $130.3M |
| Q2 2025 | 87 | $86.3M |
| Q1 2025 | 88 | $69.6M |
| Q4 2024 | 86 | $94.0M |
| Q3 2024 | 84 | $82.5M |
| Q2 2024 | 73 | $73.2M |
| Q1 2024 | 81 | $105.7M |
| Q4 2023 | 61 | $65.2M |
| Q3 2023 | 58 | $59.9M |
| Q2 2023 | 59 | $61.1M |
| Q1 2023 | 68 | $69.9M |
| Q4 2022 | 74 | $73.8M |
| Q3 2022 | 71 | $65.1M |
| Q2 2022 | 85 | $67.3M |
| Q1 2022 | 93 | $150.1M |
| Q4 2021 | 97 | $263.4M |
| Q3 2021 | 104 | $230.6M |
| Q2 2021 | 99 | $423.1M |
| Q1 2021 | 81 | $291.1M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Stereotaxis, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MetLife Investment Management | 0 | $0 | 0.00% | −19,595−100.0% | Sold out |
| Zebra Capital Management LLC | 0 | $0 | 0.00% | −12,190−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −12,032−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,846−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −5,356−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −450−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −252−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |
| AlphaCentric Advisors LLC | – | – | – | – | Not filed |